R. Grover

502 total citations
14 papers, 383 citations indexed

About

R. Grover is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, R. Grover has authored 14 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Organic Chemistry. Recurrent topics in R. Grover's work include Pulmonary Hypertension Research and Treatments (10 papers), Cardiovascular Issues in Pregnancy (3 papers) and Hemodynamic Monitoring and Therapy (2 papers). R. Grover is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Cardiovascular Issues in Pregnancy (3 papers) and Hemodynamic Monitoring and Therapy (2 papers). R. Grover collaborates with scholars based in United States, Brazil and Mexico. R. Grover's co-authors include J. T. Reeves, J. T. Maher, César De la Cruz Valencia, Joseph C. Denniston, A. Cymerman, Carlos Jerjes‐Sánchez, C. Q. Deng, Tomás Pulido, Victor F. Tapson and R. James White and has published in prestigious journals such as Circulation Research, American Journal of Respiratory and Critical Care Medicine and Journal of Applied Physiology.

In The Last Decade

R. Grover

13 papers receiving 367 citations

Peers

R. Grover

CCM

PRM

SURGE

PHYSI

A Mazzoleni United States

Hao‐Min Cheng Taiwan

K. Sunagawa Japan

Dieter Zenker Germany

AD Sperfeld Germany

Caroline Kilkowski Germany

Robert E. Durnin United States

Jay S. Meisner United States

G. Vietzke Germany

Sundip J. Patel United Kingdom

A Mazzoleni United States

R. Grover

523 ×2.5

CCM

131 ×0.8

PRM

95 ×0.7

SURGE

60 ×0.8

18 ×0.4

PHYSI

Citations per year, relative to R. Grover R. Grover (= 1×) peers A Mazzoleni

Countries citing papers authored by R. Grover

Since Specialization

Citations

This map shows the geographic impact of R. Grover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Grover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Grover more than expected).

Fields of papers citing papers by R. Grover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Grover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Grover. The network helps show where R. Grover may publish in the future.

Co-authorship network of co-authors of R. Grover

This figure shows the co-authorship network connecting the top 25 collaborators of R. Grover. A scholar is included among the top collaborators of R. Grover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Grover. R. Grover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Barberà, Joan Albert, Pavel Jansa, Elizabeth S. Klings, et al.. (2024). Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension. Advances in Therapy. 41(3). 1062–1074. 4 indexed citations

Barberà, Joan Albert, Marcos Amuchástegui, Ali Ataya, et al.. (2024). Initial Long-term Data From a Phase 3 Open-label Extension Study (ROR-PH-303) Evaluating Ralinepag for the Treatment of Pulmonary Arterial Hypertension (Advance Extension). A7379–A7379.

Khan, Akram, R. James White, G. Meyer, et al.. (2022). Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension. Respiratory Medicine. 193. 106744–106744. 9 indexed citations

Klings, Elizabeth S., et al.. (2022). Long-Term Data from Study APD811-007, an Open-Label Extension Study Evaluating Ralinepag for the Treatment of Pulmonary Arterial Hypertension. A2149–A2149. 1 indexed citations

Channick, Richard N., Victor F. Tapson, Marc Humbert, et al.. (2020). Advance Outcomes - A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in Subjects with Pulmonary Arterial Hypertension. A3819–A3819. 1 indexed citations

White, R. James, Carlos Jerjes‐Sánchez, G. Meyer, et al.. (2019). Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 201(6). 707–717. 94 indexed citations

Tapson, Victor F., Tomás Pulido, Pablo Sepúlveda, et al.. (2019). Treatment with Oral Treprostinil Delays Time to Clinical Worsening in Patients with Pulmonary Arterial Hypertension - Results from FREEDOM-EV. The Journal of Heart and Lung Transplantation. 38(4). S94–S95. 9 indexed citations

White, R.J., Carlos Jerjes‐Sánchez, Tomás Pulido, et al.. (2019). Risk Scores and Risk-Based Stratification of Clinical Worsening Events in Pulmonary Arterial Hypertension Participants Treated with Oral Treprostinil: FREEDOM-EV. A5587–A5587. 2 indexed citations

White, R.J., Ekkehard Grünig, G. Meyer, et al.. (2019). Dose-response relationship of oral treprostinil for secondary endpoints in the FREEDOM-EV study. PA5462–PA5462. 4 indexed citations

10.

Grünig, Ekkehard, Benjamin Egenlauf, Tobias Lange, et al.. (2015). Safety and tolerability of rapid dose-titration of subcutaneous (SC) treprostinil in pulmonary arterial hypertension (PAH). PA2114–PA2114. 1 indexed citations

11.

Littlewood, Janet D., et al.. (2006). Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double‐blind, placebo‐controlled clinical study. Veterinary Dermatology. 17(4). 236–243. 21 indexed citations

12.

Rose, Charles E., et al.. (1983). Right ventricular performance during increased afterload impaired by hypercapnic acidosis in conscious dogs.. Circulation Research. 52(1). 76–84. 38 indexed citations

13.

Moore, Lorna G., J. T. Reeves, D. H. Will, & R. Grover. (1979). Pregnancy-induced pulmonary hypertension in cows susceptible to high mountain disease. Journal of Applied Physiology. 46(1). 184–188. 9 indexed citations

14.

Denniston, Joseph C., J. T. Maher, J. T. Reeves, et al.. (1976). Measurement of cardiac output by electrical impedance at rest and during exercise. Journal of Applied Physiology. 40(1). 91–95. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact